EP1867334A1 — Method of relieving or avoiding side effect of steroid compound
Assigned to Santen Pharmaceutical Co Ltd · Expires 2007-12-19 · 18y expired
What this patent protects
The invention provides a method of relieving or avoiding a steroid-induced increase in intraocular pressure caused by the administration of a steroid. The steroid-induced increase in intraocular pressure can be relieved or avoided by incorporating a steroid in fine particles.
USPTO Abstract
The invention provides a method of relieving or avoiding a steroid-induced increase in intraocular pressure caused by the administration of a steroid. The steroid-induced increase in intraocular pressure can be relieved or avoided by incorporating a steroid in fine particles.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.